Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma. [electronic resource]
- The cancer journal from Scientific American
- 91-8 p. digital
Publication Type: Clinical Trial; Journal Article
1081-4442
Dose-Response Relationship, Drug Drug Resistance, Neoplasm Female Humans Immunotherapy Interleukin-2--therapeutic use Kidney Neoplasms--drug therapy Lymphocytosis--chemically induced Male Melanoma--drug therapy Middle Aged Neoplasm Metastasis--drug therapy Prognosis Recombinant Proteins--therapeutic use Thrombocytopenia--chemically induced Treatment Outcome